Search results

    Filter results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 30
Number of items: 30
  • Open Access
    Penning, A. R. A. (2025). Small RNA, big impact: Profiling the therapeutic potential of microRNA-132 in Alzheimer's disease. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Tosoni, G. (2025). New neurons, old questions: Cellular and molecular insights into the neurogenesis debate in Alzheimer’s disease. [Thesis, fully internal, Universiteit van Amsterdam].
  • de Vries, L. E., Jongejan, A., Monteiro Fortes, J., Balesar, R., Rozemuller, A. J. M., Moerland, P., Huitinga, I., Swaab, D. F., & Verhaagen, J. (2024). Additional file 3 of Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.26712281.v1
  • de Vries, L. E., Jongejan, A., Monteiro Fortes, J., Balesar, R., Rozemuller, A. J. M., Moerland, P., Huitinga, I., Swaab, D. F., & Verhaagen, J. (2024). Additional file 1 of Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.26712275.v1
  • de Vries, L. E., Jongejan, A., Monteiro Fortes, J., Balesar, R., Rozemuller, A. J. M., Moerland, P., Huitinga, I., Swaab, D. F., & Verhaagen, J. (2024). Additional file 5 of Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.26712287.v1
  • Smolders, J., Hamann, J., & Huitinga, I. (2024). Modification of T- and B-cell-associated immuno-pathologic mechanisms in multiple sclerosis by disease modifying therapies: Achievements and opportunities. In M. Aminoff, & G. L. Mancardi (Eds.), Hematopoietic Stem Cell Transplantation for Neurologic Diseases (pp. 7-21). (Handbook of Clinical Neurology; Vol. 202). Elsevier. https://doi.org/10.1016/B978-0-323-90242-7.00016-X
  • Open Access
    de Vries, L. E., Huitinga, I., Kessels, H. W., Swaab, D. F., & Verhaagen, J. (2024). The concept of resilience to Alzheimer's Disease: current definitions and cellular and molecular mechanisms. Molecular Neurodegeneration, 19, Article 33. https://doi.org/10.1186/s13024-024-00719-7
  • Open Access
    van den Bosch, A. M. R., Wever, D., Schonewille, P., Schuller, S. L., Smolders, J., Hamann, J., & Huitinga, I. (2024). Cortical CD200–CD200R and CD47–SIRPα expression is associated with multiple sclerosis pathology. Brain Communications, 6(4), Article fcae264. https://doi.org/10.1093/braincomms/fcae264
  • Open Access
    van den Bosch, A. M. R. (2024). Progression of multiple sclerosis: The role of microglia and neurons. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Mekkes, N. J., Groot, M., Hoekstra, E., de Boer, A., Dagkesamanskaia, E., Bouwman, S., Wehrens, S. M. T., Herbert, M. K., Wever, D. D., Rozemuller, A., Eggen, B. J. L., Huitinga, I., & Holtman, I. R. (2024). Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing. Nature medicine, 30(4), 1143-1153. https://doi.org/10.1038/s41591-024-02843-9
Page 1 of 3